- Home
- GCBC vs ENGN Comparison
GCBC vs ENGN Comparison
Compare GCBC & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCBC
- ENGN
- Stock Information
- Founded
- GCBC 1889
- ENGN 1999
- Country
- GCBC United States
- ENGN Canada
- Employees
- GCBC N/A
- ENGN N/A
- Industry
- GCBC Banks
- ENGN
- Sector
- GCBC Finance
- ENGN
- Exchange
- GCBC Nasdaq
- ENGN Nasdaq
- Market Cap
- GCBC 366.1M
- ENGN 379.3M
- IPO Year
- GCBC 1998
- ENGN N/A
- Fundamental
- Price
- GCBC $22.20
- ENGN $6.53
- Analyst Decision
- GCBC
- ENGN Buy
- Analyst Count
- GCBC 0
- ENGN 7
- Target Price
- GCBC N/A
- ENGN $20.29
- AVG Volume (30 Days)
- GCBC 11.5K
- ENGN 390.2K
- Earning Date
- GCBC 10-21-2025
- ENGN 12-18-2025
- Dividend Yield
- GCBC 1.79%
- ENGN N/A
- EPS Growth
- GCBC 37.86
- ENGN N/A
- EPS
- GCBC 1.98
- ENGN N/A
- Revenue
- GCBC $77,438,000.00
- ENGN N/A
- Revenue This Year
- GCBC N/A
- ENGN N/A
- Revenue Next Year
- GCBC N/A
- ENGN N/A
- P/E Ratio
- GCBC $11.23
- ENGN N/A
- Revenue Growth
- GCBC 20.85
- ENGN N/A
- 52 Week Low
- GCBC $20.00
- ENGN $2.65
- 52 Week High
- GCBC $35.34
- ENGN $9.65
- Technical
- Relative Strength Index (RSI)
- GCBC 47.70
- ENGN 38.84
- Support Level
- GCBC $21.96
- ENGN $6.62
- Resistance Level
- GCBC $23.27
- ENGN $7.49
- Average True Range (ATR)
- GCBC 0.77
- ENGN 0.87
- MACD
- GCBC 0.05
- ENGN -0.31
- Stochastic Oscillator
- GCBC 29.60
- ENGN 5.45
About GCBC Greene County Bancorp Inc.
Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.